|
|
|
|
|
Legal status
Patent not validated
| (51) | INT.CL. | A61K 48/00 | (2003.01) |
| A61K 48/005 | (2013.01) | ||
| C12N 15/86 | (2006.01) | ||
| C12N 15/86 | (2013.01) | ||
| C12N 9/64 | (2006.01) | ||
| C12N2750/14141 | (2013.01) | ||
| C12N 9/6421 | (2013.01) |
| (11) | Number of the document | 3906066 |
| (13) | Kind of document | T |
| (96) | European patent application number | 20704633.5 |
| Date of filing the European patent application | 2020-01-03 | |
| (97) | Date of publication of the European application | 2021-11-10 |
| (45) | Date of publication and mention of the grant of the patent | 2023-11-01 |
| (46) | Date of publication of the claims translation |
| (86) | Number | PCT/US2020/012131 |
| Date | 2020-01-03 |
| (87) | Number | WO 2020/142653 |
| Date | 2020-07-09 |
| (30) | Number | Date | Country code |
| 201962788324 P | 2019-01-04 | US | |
| 201962834830 P | 2019-04-16 | US |
| (72) |
LIVINGSTON, Christine , US
WADSWORTH, Samuel , US
|
| (73) |
Ultragenyx Pharmaceutical Inc. ,
60 Leveroni Court, Novato, CA 94949,
US
|
| (54) | GENE THERAPY CONSTRUCTS FOR TREATING WILSON DISEASE |
| GENE THERAPY CONSTRUCTS FOR TREATING WILSON DISEASE |